Aller au contenu principal
Profil bibliographique

Anna Bulla

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

25Publications signalées
97Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

SARS-CoV-2 and COVID-19 ResearchMultiple Myeloma Research and TreatmentsHemoglobinopathies and Related DisordersBlood groups and transfusionProtein Degradation and Inhibitors

Les publications récentes

Accès ouvert 2026 article OpenAlex

Additive effect of multiple genetic variants in SEC23B and PIEZO1 on iron metabolism dyshomeostasis in hereditary anemias

Antonella Nostroso, Roberta Marra, Barbara Eleni Rosato, Anthony Iscaro et autres

Abstract Hereditary anemias encompass a genetically heterogeneous spectrum of disorders, often involving multi‐locus inheritance, which can complicate clinical management and worsen disease severity. This study investigates the impact of the co‐inheritance of SEC23B loss‐of‐function pathogenic variants, which lead to congenital dyserythropoietic anemia …

it (code pays fourni par la source)

1 citation HemaSphere
Accès ouvert 2025 article OpenAlex

Trabecular bone score in the assessment of bone health in thalassemia major

Martina Di Noto, Anastasia Xourafa, Rosamaria Rosso, Anna Bulla et autres

Introduction: Thalassemia major (TM) has a significant impact on patients' quality of life. Osteoporosis and osteopenia are common and important complications, yet they are often underestimated. Their etiology is multifactorial, culminating in reduced bone mass, impaired remodeling, and increased fracture risk. The …

it (code pays fourni par la source)

0 citations Frontiers in Endocrinology
Accès ouvert 2025 article OpenAlex

Oxford Hip and Shoulder Scores as Potential Tools for the Early Detection of Avascular Necrosis in Apparently Unaffected Sites in Sickle Cell Disease: Results from a Prospective Cohort Study

Maddalena Casale, Giuseppe Toro, Federica Porcelli, Vincenzo Spadola et autres

Objectives: Sickle Cell Disease (SCD) has a significant impact on the musculoskeletal system. The use of the Oxford Hip (OHS) and Shoulder score (OSS) as patient-reported outcome measures (PROMs) revealed a high rate of long-term impairment in joints with a pre-existing diagnosis …

it (code pays fourni par la source)

0 citations Journal of Clinical Medicine
Accès ouvert 2025 article OpenAlex

Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience

Andrea Duminuco, Anna Bulla, Rosamaria Rosso, Maria Anna Romeo et autres

Background: Immune system impairment is frequently reported in patients affected by hemoglobinopathies due to various mechanisms, including iron accumulation, antigenic stimulation due to numerous transfusions, chronic hemolysis, and a general hyperinflammatory state. For these reasons, the antigenic immune response after a vaccine …

it (code pays fourni par la source)

3 citations Vaccines
Accès ouvert 2024 article OpenAlex

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

Vittorio Del Fabro, Uroš Markovic, Sara Frazzetto, Roberta Sciortino et autres

Background Waldenström macroglobulinemia (WM) is a rare and indolent B-cell lymphoproliferative disorder with greater incidence in elderly patients where a precise algorithm of initial therapy is still not clear. Immunochemotherapy regimen consisting of dexamethasone, rituximab, and oral cyclophosphamide (DRC) is considered a …

it (code pays fourni par la source)

0 citations Frontiers in Hematology
Accès ouvert 2023 conference-abstract OpenAlex

Luspatercept in the Treatment of Beta Thalassemia in Italy: Lights and Shadows in Clinical Practice

Barbara Gianesin, Rosamaria Rosso, Roberto Lisi, Antonietta Zappu et autres

Luspatercept has been demonstrated to reduce the need for blood transfusion with manageable side effects in clinical trials, thus receiving the approval for the treatment of anemia associated with transfusion dependent beta thalassemia in adults. However, very little data on its safety …

it (code pays fourni par la source)

1 citation Blood
Accès ouvert 2023 preprint OpenAlex

Breakthrough infection after SARS-CoV-2 vaccines in patients with hemoglobinopathies and blood-transfusion management: a single Center experience

Andrea Duminuco, Anna Bulla, Rosamaria Rosso, Marina Romeo et autres

Abstract Purpose Immune system impairment is frequently reported in patients affected by hemoglobinopathies due to various mechanisms, including iron accumulation, antigenic stimulation due to numerous transfusions, chronic hemolysis, and a hyperinflammatory state. The antigenic immune response after a vaccine could be ineffective. …

it (code pays fourni par la source)

0 citations Research Square
Accès ouvert 2023 article OpenAlex

Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study

Vittorio Del Fabro, Mary Ann Di Giorgio, Valerio Leotta, Andrea Duminuco et autres

Based on the results obtained in clinical trials, the use of the combination of lenalidomide and dexamethasone (Len/Dex) has become a potential therapeutic choice for newly diagnosed multiple myeloma (NDMM) ineligible for autologous stem cell transplantation. This study evaluated 89 frail NDMM …

it (code pays fourni par la source)

8 citations Cancers
Accès ouvert 2023 article OpenAlex

PB2534: SARS-COV-2 IMMUNIZATION AFTER VACCINES IN PATIENTS WITH HEMOGLOBINOPATHY: A SINGLE CENTER EXPERIENCE

Andrea Duminuco, Anna Bulla, Rosamaria Rosso, Marina Romeo et autres

Topic: 27. Thalassemias Background: Hemoglobinopathies are a heterogeneous group of inherited disorders characterized by alterations in hemoglobin synthesis. Immune system status of these patients is known to be altered due to underlying pathophysiological mechanisms of the disease, such as ineffective erythropoiesis (IE), …

it (code pays fourni par la source)

0 citations HemaSphere
Accès ouvert 2023 article OpenAlex

P59 ACTIVE TREATMENT AND LOW IGM ARE ASSOCIATED WITH INFERIOR SARS-COV-2 SPIKE ANTIBODY RESPONSE TO THREE DOSES OF COVID-19 RNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA

Andrea Duminuco, Alessandra Romano, Daniela Leotta, Enrico La Spina et autres

Introduction: Patients with multiple myeloma (MM) frequently present with substantial immune impairment and an increased risk for infection-related mortality. From the end of January 2020, infection by SARS-CoV-2 has radically changed our lives. Since the COVID-19 (COronaVIrus Disease-2019) pandemic is still ongoing, …

it (code pays fourni par la source)

0 citations HemaSphere
Accès ouvert 2023 article OpenAlex

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

Andrea Duminuco, Alessandra Romano, Dario Leotta, Enrico La Spina et autres

Introduction: Patients with multiple myeloma (MM) frequently reported immune impairment with an increased risk for infection-related mortality. We aimed to evaluate the immune response in MM patients vaccinated for SARS-CoV-2 during active treatment. Methods: We enrolled 158 patients affected by active MM …

it (code pays fourni par la source)

14 citations Frontiers in Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.